Stem Cell Banking Market Size 2021

Stem cell banking offers people, an opportunity to have their cells cryogenically frozen at a time when they are perfectly healthy. The cells can be stored and kept safely for decades. Years later, people can use those cells at the time of requirement which can be during old age. Today as the medical science progresses, processes regarding stem cell collection and safe-keeping are safe, non-invasive and risk free. In the coming years, stem cell therapies can benefit many people. Hence, the market stem cell banking is growing.

Access Full Report Details and Order this Premium Report @ https://www.absolutemarketsinsights.com/reports/Stem-Cell-Banking-Market-2021---2029-860

Major Key Players:

Some of the major players operating in the global Stem Cell Banking Market Size are CBR Systems, Inc., Cell Care, CHA Biotech, CordBank New Zealand, Cordlife, Cryo-Cell, CryoHoldco, Cryoviva India, CSG-BIO, Global Cord Blood Corporation., LifeCell International Pvt. Ltd., ReeLabs Pvt. Ltd., Regrow Biosciences Pvt Ltd., Smart Cells International Ltd., Stem Med Pte Ltd, StemCyte, ViaCord and Vita 34 Inc. amongst others.

Key findings of the report:

The global Stem Cell Banking Market Size is anticipated to reach US$ 15089.64 Mn by 2029 growing at a CAGR of 10% during the forecast period (2021-2029).

Umbilical cord accounted for the largest source in the global Stem Cell Banking Market Size in 2020. Cord blood stem cells can be used in therapies and transplants to treat over 85 ailments that include anaemias (different types), bone marrow cancer, leukaemias (different types), and lymphomas. More than 5,000 clinical trials are using stem cell therapies today.

In the context of medical condition, higher market share in the global Stem Cell Banking Market Size was held by cancer (leukaemias, lymphomas, etc.) in 2020. Stem cells can be used for the treatment of different types of cancer such as acute biphenotypic leukemia, acute lymphoblastic leukemia, acute myelogenous leukemia, acute undifferentiated leukemia, chronic myelogenous leukemia, chronic lymphocytic leukemia, juvenile myelomonocytic leukemia, and juvenile chronic myelogenous leukemia. In regenerative medicine, the use of stem cells has been in vogue for a long time. It is very common in the field of dermatology.

Considering the applications segment, the disease treatment & tissue regeneration segment occupied the largest market share in 2020. Stem cells that are used in disease treatment & tissue regeneration have the potential to treat various medical conditions including different types of blood cancers. They can also treat various disorders such as genetic disorders, immunity-related disorders, and metabolic disorders. The US FDA has approved the use of cord blood stem cells for the treatment of 80 diseases. Through replacement and repair approaches, stem cells are used in many medicine. Regarding tissue regeneration, stem cells can be used for repairing and restoring the damaged tissues or organs. This treatment is helpful in case of severe injuries and chronic diseases. Such stem cells can generate healthy cells that can replace diseased cells.

In 2020, North America dominated the global Stem Cell Banking Market Size. Advanced medical research being carried out in many biology-based scientific institutions in USA and Canada is aiding the region’s growth in the global market. Developed medical sector, presence of key market players, technological advancement aiding medical research, and higher investment in medical research are some other major factors that contributed to the market growth in this region.

Market Segmentation

By Service Type

Storage 

Testing and Processing

Collection 

By Source

Umbilical Cord 

Placenta

Amniotic Fluid

Bone Marrow

Others

By Medical Condition

Cancer (Leukaemias, Lymphomas, Etc.)

Non Malignant Blood Disorders (Anaemias, Hereditary Bone Marrow Failure Syndromes, Etc.)

Immune Disorder (Severe Combined Immune Deficiency (SCID), Inherited Immune System Disorders, etc.)

Metabolic Disorders (Leukodystrophy Disorders, Mucopolysaccharidosis (MPS) Storage Diseases, Etc.)

Others

By Application

Disease Treatment & Tissue Regeneration

Clinical Research

Personalized Banking Applications

By Region

North America

U.S.

Canada

Mexico

Rest of North America

Europe

France

The UK

Spain

Germany

Italy

Nordic Countries

Denmark

Finland

Iceland

Sweden

Norway

Benelux Union

Belgium

The Netherlands

Luxembourg

Rest of Europe

Asia Pacific

China

Japan

India

New Zealand

Australia

South Korea

Southeast Asia

Indonesia

Thailand

Malaysia

Singapore

Rest of Southeast Asia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Egypt

Kuwait

South Africa

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

.…

Contact us:

Shreyas Tanna

Phone: +91-740-024-2424

Absolute Markets Insights

Email: sales@absolutemarketsinsights.com